Member Info for bignose58

Although Heimdal is correct in that majors buy minnows after completing the phase II, this has been discussed on this very board since the days of "We are at heads of terms with a US licensee "back in March 2014.

My feeling is and it goes against what I have been fantasizing about is that. Given how it was meant to be a blockbuster product, why was the EU deal carp, why was the Chinese deal even worse and why has a US pharma not stepped up to the plate sooner ??? Any licensee could have easily purchased a large % of shares over the years to offset any offer. I cannot help but feel that the current management have no clue regarding making pharma deals and will more than likely allow themselves to be shafted, unless of course a US licensee sees no blockbuster value in the product.

The SP will go up, I am sure, once a US deal is announced, but the value of that deal will undoubtedly be much less than we possibly are expecting.

Also, the EU and Asian licenses could cause a problem for an outright sale given something detrimental must be written within the current deals to account for such a possibility as they surely wouldn't want themselves to be exposed. The company would have been better seeking the FDA approval from the very beginning - we would have gotten it by now and any offer now surely wont be dragged down by the "disappointing sales".

I am ever hopeful that they do offload the license for the whole of the Americas including Canada, but it remains to be seen if anything is forthcoming and would the offer be of value? I remember Dr M stated in the media long ago that they would not accept anything less than 1 billion USD. Could this be the reason prospective licensees may have walked all those years ago thinking we were being too unrealistic and greedy ?

Hopefully my speculating is proved totally wrong.

As always Fingers, legs n anything else available crossed.

Morning Keith, The.Italian.

I must admit. I do admire your writings which are usually well put together and using words I have to look up … Unlike myself, I have to work at it. Sometimes rewriting as I don’t even understand my own content…I get truly discombobulated...lol.

Anyway. Referring to my topic. WTF. If there was ever market manipulation going on, it just happened less than 1 min to close. 10k shares (being one miserly lot) and it goes up 5%. But why ??? It certainly make absolute no sense (A bit like the bod, I guess) ;-).

The.Italian.

I’m afraid there is a big difference in content between ? and some of the big words Keith has used in the past, so nothing to be sorry about. Mind you, I’m even having a problem getting my e’s n i’s in the correct order (sorry Keith). Dyslexia rules KO……lol

Or even….

discombobulate RP. (Another of Bothwells or were they Kieths ?. I’m a little discombobulated about it….lol)

New names anyone ?

Confusion RP
Aboutturn RP
Incompetence RP
WeThoughtWeWasPharma RP
WeThoughtWeWasMiners RP
WeGiveUp RP

Please send suggestions to JM and JG care of ERP.
Competition results will be made available through the usual announcement channels.
Closing date 25th Dec 2021.

Soooo. Now here is a conundrum. What if DVP becomes worth billions or is bought out for billions. Will there be another change in direction back to mining with another name change !!!. At least they DO have experience in that direction……… Money talks louder than words n est pa ?

Morning The.Italian.

Maybe they will, although they have only so far used it towards the AT bill. Hopefully they can squeeze a decent US license deal up front payment to at least take us through to US first sales. (I’m not so optimistic now about it being a really good deal based on their previous examples).

Well the market obviously doesn’t consider it contributory given we’ve dropped about 15% in less than 2 weeks.

Certainly not going to see any news now we have entered December and a closed period. Although there have on occasions been updates in a closed period, I’m pretty sure they will use any excuse not to provide one. Obviously C-19 being the main one. They will probably suggest it has infected their computers and prevented the use of word or a pdf writer…..lol. Given they are pretend Pharma experts, they are probably unaware that the C-19 and computer viruses are two totally different things….. ce la vie.

That said, I do wonder on the license talks. It would certainly appear to be taking a long time given they were at heads of terms (shareholders have never been advised otherwise), we have done the groundwork in producing a market research paper by supposed industry experts and they have asked and received additional data (not sure why they need this when they must have had it long before and the EU is now approved as OTC). I worry that we do not have the right caliber of people in the discussions after seeing the results of the China fiasco.

The company must surely be running on oxygen now given the drain on whatever money the company had by EP, PLE and now DLI, which, still after a year, is a non starter.

What will 2022 bring shareholders ???

And come December, which is knocking at the door, we will one again be in a closed period whilst they sort out the end of year profit warning .....

Probably not before JM tells JG he wont be paid anymore salary until he pulls his finger out and does some work.....pigs might fly comes to mind.

The.Italian,

Although slightly different markets, they are related with respect to sexual disfunction which I am sure certain companies specialise in. Pfizer, for example, apparently only went forward with Viagra since they developed it and ultimately realised the potential, however. I would certainly be surprised if they had any interest in any other sexual products since they mainly specialise in other areas. I could be wrong since I guess no company would miss the chance of a possible billion dollar additional income, although Pfizer and some of the other larger pharma's do earn billions elsewhere.

Anyroadup. It was just a passing thought to pass the time ;-)

The.Italian.

Just a thought, but wouldn’t both PLE and FUM be in US license discussions with possibly the same companies ? If so, could one not influence the other depending what sort of license deal is being discussed. Ie how much dosh being made available to one or the other, depending on what is regarded as having the most commercial success ? Just a thought (shrugging of shoulders).

Dougie,

It goes without saying. Especially since the value attributable to just being listed on the HK stock exchange is apparently worth about 40mill squid. Unfortunately, as mentioned before the current price is being driven by day traders mostly who from experience jump on when the stock rises following news. It would certainly appear they have no interest in what the company has or what its supposed value should be. This will only change once a few institutions have an interest. And that will only happen when the company is seen to make consistent, sustainable gains.

Morning The.Italian.

Of course IF (and that's a really big IF) they do manage to get a good deal from the US license talks, I am sure it will all change as I am sure institutions will start to take an interest. Unfortunately going by their so called professional track record at making lucrative deals would indicate we are in for no such luck. One only has to look at the Chinese numbers. 1.5 billion people with 750mill men leading to supposedly 187.5 mill sufferers. even with a 20th of that figure one would be looking at projected sales of about 1 bill usd, yet the license deal is a catastrophe. up front payments certainly don't reflect anything more than a single region in the EU !!!

They really should have gotten more experienced people in with several pharma deals up their sleeves. Instead we are stuck with a CEO and BOD who only know how to go out n ask for funding for mining investments which is a totally different ball game.

Not in the UK, thats for sure. HK n China is another question, however. I really don’t think there are many large holders as one just has to look at the AGM/EGM vote numbers. Next to none against which makes no sense. As such, I would say most are small holders who don’t care what the company has, they just trade the stock for all its worth.

Thats right. Dr Mike is indeed a seasoned pharma professional who I am in regular contact with, however. Even he is kept in the dark with the operations of the company who do not discuss certain matters with him and he's meant to be the chief scientific officer !!!!. He and the product go hand in hand hence why I invested long before the clowns came to town with their incompetence, lies and misinformation.

The clowns may have, as you correctly write, skin in the game, however. All Jamie's shares have either been given to him or he has purchased via placings at discounted prices and even as loans, where he will never lose, using money from his disgustingly oversized salary (how many other companies can you say have a CEO on a salary at such a huge % of market valuation ?). He has never bought shares on the open market as most other CEO's do to indicate support. The company is run as if it is a private enterprise given they changed the usual 5% requirement to call an EGM to 25% (now 20%), so nigh impossible to have anything changed. And Jim's investment was from pocket change through his annual income on what is it now, 1 billion squid ??? So how much skin just depends on where that skin comes from to give a certain incentive.

All you have to do to gauge the incompetence is to reread all the RNS's, announcements and annual reports where not one date has ever been met and with no clarifications as to what has happened, let alone all the deliberately misleading information contained therein. It certainly doesn't appear to be the workings of a well oiled professional company with shareholders value in mind does it.

And just as a reminder:
Shareholder value is the value given to stockholders in a company based on the firm's ability to sustain and grow profits over time.

In the last 9 years since when the last divi was made, shareholders have seen nothing but absolute destruction to their investment, no ?

Heimdal,

Now what makes you write that. Its not like I keep reminding everyone what a bunch of clowns they are.....lol

No, I, like many, don't. They have shown themselves many many (as in many) times to be totally incompetent and out of their depth with getting the product to market as well as trying to convince everyone they are experienced pharma investors...NOT. They lie through their teeth and hide behind smoke n mirrors. It is quite obvious the market has nothing but contempt for them otherwise the sp and market cap wouldn't be this low.

That said, I have faith in the product which will eventually come to market and which is all I am interested in.

Heimdal's back..... where's you bin. I mean where's you wheelie bin ...... as the dustman said to the home owner.....lol

Pity DLI is heading down the same road as the DBC although unlike the DBC, DLI are taking a lot of investors money with it (salaries, operating costs.....etc), but still no return on our investment.

I alluded to that same thing (market manipulation) a year ago when RPG made a bid for DLI. It still stinks even today.

The nada is because they are incompetent and arrogant. JG needs to be replaced by my pet dog ASAP for the better of investors investment and a floundering sp.

So, a little bird tells me the submission was indeed made a couple of months ago and they are probably currently going through a question and answer period, although if they have been honest (which I highly doubt) about having constant contact with the FDA, who we were advised gave an unambiguous way forward in 2014, there surely cannot be much in the way of Q&A's, particularly with the "better than expected" results announcements ???

That said, JG is a TWAT of the highest degree for not advising the market the submission had been made given they had made announcements containing unmet dates. Also, if an announcement had been forthcoming, I am pretty sure we would not have seen the recent 20% drop in sp. We may even have witnessed a well deserved boost as a result. Once again, incompetence and inexperience at its best and yet he still gets paid for it. Pretty unbelievable really !!!!

The company name should have been changed to "Incompetence RP" as it's more inline with the service they provide.....